Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Mannaerts

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Human Reproduction (Oxford, England)|June 1, 1993
First established pregnancy and birth after ovarian stimulation with recombinant human follicle stimulating hormone (Org 32489)P Devroey, B Mannaerts, J Smitz, et al.
Human Reproduction (Oxford, England)|June 1, 1994
Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimensP Devroey, B Mannaerts, J Smitz, et al.
Annales D'Endocrinologie|January 1, 1994
The use of recombinant FSH for ovulation inductionJ Smitz, P Devroey, B Mannaerts, et al.
Human Reproduction (Oxford, England)|November 1, 1993
Effects of recombinant human follicle stimulating hormone on cultured human granulosa cells: comparison with urinary gonadotrophins and actions in preovulatory folliclesH D Mason, B Mannaerts, R de Leeuw, et al.
Fertility and Sterility|February 1, 1996
Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadismB Mannaerts, B Fauser, N Lahlou, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 8, 2023
Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approachM Fernández-Sánchez, H Fatemi, J A García-Velasco, et al.
Human Reproduction (Oxford, England)|September 2, 1999
High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cyclesS Kol, A Lightman, T Hillensjo, et al.
Endocrinology|November 1, 1991
Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormoneB Mannaerts, R de Leeuw, J Geelen, et al.
Fertility and Sterility|January 1, 1993
Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteersB Mannaerts, Z Shoham, D Schoot, et al.
Human Reproduction (Oxford, England)|February 1, 1995
A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilizationP Devroey, K Tjandraprawira, B Mannaerts, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Human Reproduction (Oxford, England)|June 1, 1993
First established pregnancy and birth after ovarian stimulation with recombinant human follicle stimulating hormone (Org 32489)P Devroey, B Mannaerts, J Smitz, et al.
Human Reproduction (Oxford, England)|June 1, 1994
Clinical outcome of a pilot efficacy study on recombinant human follicle-stimulating hormone (Org 32489) combined with various gonadotrophin-releasing hormone agonist regimensP Devroey, B Mannaerts, J Smitz, et al.
Annales D'Endocrinologie|January 1, 1994
The use of recombinant FSH for ovulation inductionJ Smitz, P Devroey, B Mannaerts, et al.
Human Reproduction (Oxford, England)|November 1, 1993
Effects of recombinant human follicle stimulating hormone on cultured human granulosa cells: comparison with urinary gonadotrophins and actions in preovulatory folliclesH D Mason, B Mannaerts, R de Leeuw, et al.
Fertility and Sterility|February 1, 1996
Serum hormone concentrations during treatment with multiple rising doses of recombinant follicle stimulating hormone (Puregon) in men with hypogonadotropic hypogonadismB Mannaerts, B Fauser, N Lahlou, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|May 8, 2023
Incidence and severity of ovarian hyperstimulation syndrome (OHSS) in high responders after gonadotropin-releasing hormone (GnRH) agonist trigger in "freeze-all" approachM Fernández-Sánchez, H Fatemi, J A García-Velasco, et al.
Human Reproduction (Oxford, England)|September 2, 1999
High doses of gonadotrophin-releasing hormone antagonist in in-vitro fertilization cycles do not adversely affect the outcome of subsequent freeze-thaw cyclesS Kol, A Lightman, T Hillensjo, et al.
Endocrinology|November 1, 1991
Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormoneB Mannaerts, R de Leeuw, J Geelen, et al.
Fertility and Sterility|January 1, 1993
Single-dose pharmacokinetics and pharmacodynamics of recombinant human follicle-stimulating hormone (Org 32489*) in gonadotropin-deficient volunteersB Mannaerts, Z Shoham, D Schoot, et al.
Human Reproduction (Oxford, England)|February 1, 1995
A randomized, assessor-blind, group-comparative efficacy study to compare the effects of Normegon and Metrodin in infertile female patients undergoing in-vitro fertilizationP Devroey, K Tjandraprawira, B Mannaerts, et al.
Pageof 3